These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Camras CB; Siebold EC; Lustgarten JS; Serle JB; Frisch SC; Podos SM; Bito LZ Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003 [TBL] [Abstract][Full Text] [Related]
10. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Rulo AH; Greve EL; Geijssen HC; Hoyng PF Ophthalmology; 1996 Aug; 103(8):1276-82. PubMed ID: 8764799 [TBL] [Abstract][Full Text] [Related]
11. The effect of d-timolol on intraocular pressure in patients with ocular hypertension. Keates EU; Stone R Am J Ophthalmol; 1984 Jul; 98(1):73-8. PubMed ID: 6742081 [TBL] [Abstract][Full Text] [Related]
12. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes. Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cagil N Int J Clin Pharmacol Res; 1996; 16(2-3):51-5. PubMed ID: 9063756 [TBL] [Abstract][Full Text] [Related]
13. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits. Goh Y; Nakajima M; Azuma I; Hayaishi O Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567 [TBL] [Abstract][Full Text] [Related]
14. The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma. Prünte C; Flammer J Ophthalmology; 1995 Sep; 102(9):1291-7. PubMed ID: 9097765 [TBL] [Abstract][Full Text] [Related]
15. [Ocular effects of topical instillation of UF-021 ophthalmic solution in healthy volunteers]. Takase M; Murao M; Koyano S; Okita M; Ueno R Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1261-7. PubMed ID: 1442350 [TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Tanihara H; Inatani M; Honjo M; Tokushige H; Azuma J; Araie M Arch Ophthalmol; 2008 Mar; 126(3):309-15. PubMed ID: 18332309 [TBL] [Abstract][Full Text] [Related]
18. Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye. Kaplan-Messas A; Naveh N; Avni I; Marshall J Eur J Ophthalmol; 2003; 13(1):18-23. PubMed ID: 12635670 [TBL] [Abstract][Full Text] [Related]